Uncovering the mechanisms of exertional dyspnoea in combined pulmonary fibrosis and emphysema Source: Eur Respir J, 55 (1) 1901319; 10.1183/13993003.01319-2019 Year: 2020
Mechanisms and consequences of exertional dyspnoea in combined pulmonary fibrosis and emphysema (CPFE) Source: International Congress 2019 – Exercise physiopathology in various respiratory diseases Year: 2019
Common mechanisms of exertional dyspnoea in chronic lung disorders Source: International Congress 2018 – Dyspnoea: a multidimensional and multidisciplinary approach Year: 2018
Acidotic responses in patients with idiopathic pulmonary fibrosis: The mechanisms of exertional dyspnea Source: Annual Congress 2012 - Pathophysiological mechanisms in disease: new insights Year: 2012
Physiological predictors of exertional oxygen desaturation in patients with fibrotic interstitial lung disease Source: Eur Respir J, 55 (2) 1901681; 10.1183/13993003.01681-2019 Year: 2020
Patterns of cardiopulmonary response to exercise in lung diseases Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-49-5, page=69 Year: 2007
Functional and psychological correlates to exercise dyspnea in patients with abnormal ventilatory impedance due to COPD or interstitial lung disease or obesity Source: Annual Congress 2011 - Clinical physiology for clinical problems Year: 2011
Mechanisms of exertional dyspnoea in pulmonary veno-occlusive disease with EIF2AK4 mutations Source: Eur Respir J 2014; 44: 1069-1072 Year: 2014
Respiratory muscle perfusion limitations and dyspnoea during cycling in chronic obstructive pulmonary disease Source: Virtual Congress 2020 – From respiratory physiology to diagnosis and treatment Year: 2020
Effects of hyperoxia on dyspnoea and exercise endurance in fibrotic interstitial lung disease Source: Eur Respir J, 49 (5) 1602494; 10.1183/13993003.02494-2016 Year: 2017
Idiopathic interstitial pneumonia and connective tissue disorder-related interstitial lung disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=170 Year: 2007
Muscle wasting and dynamic hyperinflation in chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 277s Year: 2007
Moderate resting hypoxaemia in fibrotic interstitial lung disease Source: Eur Respir J, 57 (1) 2001563; 10.1183/13993003.01563-2020 Year: 2021
Possible mechanisms underlying the development of cachexia in COPD Source: Eur Respir J 2008; 31: 492-501 Year: 2008
Impact of nebulized fentanyl on exertional dyspnea in interstitial lung disease Source: International Congress 2019 – Exploring exercise responses in respiratory diseases Year: 2019
Understanding the different physiology behind breathlessness due to obstructive and restrictive lung diseases Source: Annual Congress 2009 - PG10 Self management in chronic respiratory disease Year: 2009
Longitudinal clinico-physiological behaviour of interstitial lung disease in the idiopathic inflammatory muscle syndromes Source: Annual Congress 2010 - Different patterns of interstitial lung disease Year: 2010
Nitrofurantoin-induced interstitial lung disease Source: Annual Congress 2012 - Viral infections and rare respiratory infections Year: 2012
Effects of peripheral muscle training on dyspnoea and leg pain in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 188s Year: 2001
Diaphragmatic dysfunction evaluated by ultrasound correlates with dyspnea, exercise and quality of life in interstitial lung disease Source: International Congress 2016 – Dyspnoea and respiratory muscle/mechanics anomalies in disease Year: 2016